Featured Content

Targeted Therapy with Tyrosine Kinase Inhibitors 10/17/2008

ABSTRACT: Tyrosine kinases are a family of proteins that contribute to the development of cancer.

IMATINIB

Management of Chronic Myelogenous Leukemia 7/13/2007

ABSTRACT: Chronic myelogenous leukemia (CML) is a hematologic malignancy associated with chromosomal abnormalities, including the Philadelphia chromosome (Ph).

Advertisement